#Gilead Sciences

The U.S. Business Action to End HIV coalition boosts public-private partnerships and spells out six ways companies can fight the epidemic.

A $4.5 million joint effort aims to address health inequities in three cities.

Held in Puerto Rico, #2022USCHA highlighted HIV in Latino populations, language justice, storytelling, music and much more.

Wake Forest University’s Faith Coordinating Center launched the Black Faith and HIV initiative with hopes of building a national movement.

Gilead Sciences, the Morehouse School of Medicine and Xavier University boost HIV care for Black Americans in a COVID-impacted South.

Gilead, ViiV, NMAC, HRC, NBJC, GLAAD and others offer $5.5 million in grants to help community groups respond to monkeypox.

Gilead Sciences’ COMPASS Initiative funds the Transformative Grants to bolster HIV groups in the South.

The massive display marked the AIDS Memorial Quilt’s 35th anniversary and a return to its birthplace. Alas, rain cut the event short.

Several makers of hepatitis C drugs are limiting health care providers’ access to the 340B Drug Pricing Program’s discounts.

Gilead Sciences’ “Zeroing In” program helps 116 grantees boost HIV innovation, education and outreach in marginalized communities.

In its 30th year, Elton John’s Oscar viewing party raised $8.6 million. Plus: Lil Nas X and Gilead fight HIV in the South.

In January, Gilead Sciences claimed that over $250 million in counterfeit meds were sold and that it had sued the illegal distributors.

MTV Real World star Pedro Zamora would have turned 50 this week. These youth scholarships honor his AIDS education legacy.

In a letter to federal officials, PrEP4All and HIV advocates demand an update on the drug patent lawsuit “United States v. Gilead.”

“He’s our Beyoncé!”

The weekly series of videos arrives as Gilead Sciences awards $16.6 million in grants to programs helping people aging with HIV.